Alluvi, previously BI 4744, presents a notable breakthrough in weight management treatment. This dual stimulator targeting both GLP-1 and GIP targets demonstrates compelling efficacy in research studies, arguably https://alluvi-research.co.uk/product/alluvi-retatrutide-40mg-rd-only/